Twist Bioscience Corporation (0ME)
XSTU
Closed
Oct 8, 2026
Day's Range
131.8552 wk Range
22.14Overview - 0ME - Twist Bioscience Corporation
Key Statistics
Valuation
Enterprise Value
-107.47M
P/E (Trailing)
‪-123.50‬
EV / EBITDA
‪0.67‬
Profitability
Gross Margin
‪52.75%‬
Profit Margin
‪50.72%‬
Operating Margin
‪-36.18%‬
Return on Assets
‪-12.10%‬
Return on Equity
‪-16.42%‬
Ownership
Shares Outstanding
62.67M
Price stats
50-Day Avg
‪30.62‬
200-Day Avg
‪27.67‬
Peers - 0ME - Twist Bioscience Corporation
Peer Comparison
Compared with companies in Diagnostics & Research listed on XSTU.
- 0MEXSTUTwist Bioscience Corporation+85.77%52-week change-123.50P/E (Trailing)‪50.72%‬Profit Margin
- NL0XSTUGRAIL, Inc.+55.16%52-week change-9.98P/E (Trailing)‪-236.94%‬Profit Margin
- 1K9XSTUCareDx Inc.+77.34%52-week change-138.75P/E (Trailing)‪67.55%‬Profit Margin
- ILUXSTUIllumina Inc.+67.25%52-week change43.70P/E (Trailing)‪66.08%‬Profit Margin
- NG9XSTUNeoGenomics, Inc.+60.85%52-week change-20.33P/E (Trailing)‪43.21%‬Profit Margin
- RV6XSTUCharles River Laboratories International, Inc.+51.37%52-week change-87.94P/E (Trailing)‪32.95%‬Profit Margin
- WX8XSTUWuXi AppTec Co., Ltd.+48.80%52-week change3.50P/E (Trailing)‪47.63%‬Profit Margin
Profile Summary - 0ME - Twist Bioscience Corporation
About
Twist Bioscience Corporation is a synthetic biology company that develops and sells DNA-based products for research and commercial applications. Twist Bioscience Corporation’s portfolio includes synthetic genes, gene fragments, oligonucleotide pools, and antibody libraries used in therapeutic discovery, diagnostics,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
